NASDAQ: CNTB
Connect Biopharma Holdings Ltd Earnings Dates, Reports, Calls

Connect Biopharma Holdings earnings were N/A for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest CNTB earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$10.3M, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CNTB reported annual earnings of -$15.6M, with -74.8% growth.

CNTB earnings history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

CNTB Return on Equity

Insufficient data to display

CNTB undefined

Insufficient data to display

Be the first to know when CNTB announces earnings.

CNTB undefined

Current Company
0%
Current Industry
5.8%

CNTB vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CNTBN/AN/AN/AN/A
ATRA$7.38M-$15.64MN/A-$2.57
ONCY-$22.13M-$22.50MN/A-$0.29
IFRX-$50.25M-$50.82MN/A-$0.85
AVTX$70.18M$73.01MN/A-$4.01

Connect Biopharma Holdings Earnings Reports & History FAQ

What were Connect Biopharma Holdings's earnings last quarter?

Connect Biopharma Holdings (NASDAQ: CNTB) reported Q1 2025 earnings per share (EPS) of -$0.19, up 18.75% year over year. Total CNTB earnings for the quarter were -$10.27 million. In the same quarter last year, Connect Biopharma Holdings's earnings per share (EPS) was -$0.16.

If you're new to stock investing, here's how to buy Connect Biopharma Holdings stock.

Is Connect Biopharma Holdings profitable or losing money?

As of the last Connect Biopharma Holdings earnings report, Connect Biopharma Holdings is currently losing money. Connect Biopharma Holdings's net profit (also called net income) for the twelve months ending Mar 31, 2025 was N/A, a N/A decrease year over year.

What was CNTB's earnings growth in the past year?

As of Connect Biopharma Holdings's earnings date in Q2 2025, Connect Biopharma Holdings's earnings has grown year over year. CNTB earnings in the past year totalled N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.